| Name | Title | Contact Details |
|---|
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
National Dentex Corporation is a network of local dental labratories providing the competitive pricing and resources of a large laboratory along with the personalized support of a local lab. NDX has more than 40 locations across the United States and Canada.
Family Home Health Services is a Monroeville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NHOH is a Hooksett, NH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
InnFocus, Inc., an early stage company pioneering a microsurgical solution for glaucoma.InnFocus is an ophthalmology company founded in 2003 with extensive biomaterials experience that develops and provides next generation products for glaucoma surgery. Glaucoma is a disease for which there is no cure, is the second leading cause of blindness in the world and afflicts an estimated 60 million people worldwide.